Sarcoidosis

clock

Anne Llewellyn examines the consequences and underwriting ramifications of this little known disease.

Sarcoidosis is a progressive, inflammatory disease of unknown cause characterised by the formation of granulomas, abnormal nodules of inflamed tissue that can affect any organ, altering its structure and function. It primarily affects young and middle aged adults. Around 20% of those diagnosed with sarcoidosis will experience functional impairment, and the mortality rate is about 5%. A disclosure of sarcoidosis is therefore significant at underwriting stage, but as 80% of sufferers have no impairment the majority of applicants with this condition will be accepted at standard rates or wit...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Protection

Record protection payouts must spur advisers on

Record protection payouts must spur advisers on

These aren't products that sell themselves

Ahmed Bawa
clock 01 November 2024 • 5 min read
Could a broader advice definition boost protection's reach?

Could a broader advice definition boost protection's reach?

'No one wakes up in the morning thinking about buying life insurance'

Paul Yates
clock 22 October 2024 • 4 min read
Are we talking enough about protection and succession planning?

Are we talking enough about protection and succession planning?

Why are more IHT liabilities for gifts not being protected?

Naomi Greatorex
clock 30 September 2024 • 4 min read